Uses Philips iSuite during MRI-guided procedures
Part of Cancer clinical trials.
This study tests a software tool (Philips iSuite) to help doctors during MRI-guided, minimally invasive procedures. You may be able to participate if you’re already scheduled for this type of procedure, unless you are pregnant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You already have an MRI-guided procedure scheduled (a minimally invasive procedure using MRI).
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a way of planning and delivering radiation using MRI pictures to help target tumors more accurately. It may benefit people by improving how radiation is aligned, and it’s being tested for safety and effectiveness compared with the usual CT-based planning.
This study tests an imaging software that helps make CT images clearer and sharper, especially when guiding needles or other instruments during procedures. If you have already had a qualifying CT scan, this study may help improve how procedures are guided in the future.
This trial tests if using MRI and a blood test called PHI can help decide who needs a prostate biopsy. It aims to avoid unnecessary biopsies while still catching cancer early.
This study tests a new augmented reality system to help doctors place needles in the liver during MRI scans for biopsies or ablation (heat to destroy tumors). The goal is to see if it improves accuracy and speed.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.